BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33765452)

  • 1. Comparison of inflammatory, nutrient, and neurohormonal indicators in patients with schizophrenia, bipolar disorder and major depressive disorder.
    Lyu N; Xing G; Yang J; Zhu X; Zhao X; Zhang L; Wang G
    J Psychiatr Res; 2021 May; 137():401-408. PubMed ID: 33765452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.
    Yin B; Cai Y; Teng T; Wang X; Liu X; Li X; Wang J; Wu H; He Y; Ren F; Kou T; Zhu ZJ; Zhou X
    Transl Psychiatry; 2024 Mar; 14(1):163. PubMed ID: 38531835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
    Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
    Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
    Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The severity of inflammation in major neuropsychiatric disorders: comparison of neutrophil-lymphocyte and platelet-lymphocyte ratios between schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and obsessive compulsive disorder.
    Bulut NS; Yorguner N; Çarkaxhiu Bulut G
    Nord J Psychiatry; 2021 Nov; 75(8):624-632. PubMed ID: 34319861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between major depressive disorder and bipolar disorder by auditory steady-state responses.
    Isomura S; Onitsuka T; Tsuchimoto R; Nakamura I; Hirano S; Oda Y; Oribe N; Hirano Y; Ueno T; Kanba S
    J Affect Disord; 2016 Jan; 190():800-806. PubMed ID: 26625092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transdiagnostic comparison of affective decision-making in patients with schizophrenia, major depressive disorder, or bipolar disorder.
    Gu YT; Zhou C; Yang J; Zhang Q; Zhu GH; Sun L; Ge MH; Wang YY
    Psych J; 2020 Apr; 9(2):199-209. PubMed ID: 32077267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intelligence decline across major depressive disorder, bipolar disorder, and schizophrenia.
    Ohi K; Takai K; Sugiyama S; Kitagawa H; Kataoka Y; Soda M; Kitaichi K; Kawasaki Y; Ito M; Shioiri T
    CNS Spectr; 2021 Mar; ():1-7. PubMed ID: 33731244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of automatic visual attention in schizophrenia, bipolar disorder, and major depression: Evidence from P1 event-related component.
    Spironelli C; Romeo Z; Maffei A; Angrilli A
    Psychiatry Clin Neurosci; 2019 Jun; 73(6):331-339. PubMed ID: 30882991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different levels of prepulse inhibition among patients with first-episode schizophrenia, bipolar disorder and major depressive disorder.
    Sun Y; Bo Q; Mao Z; Tian Q; Dong F; Li L; Wang C
    J Psychiatry Neurosci; 2024; 49(1):E1-E10. PubMed ID: 38238035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio, lymphocyte/high-density lipoprotein ratio, and monocyte/high-density lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder.
    Wei Y; Wang T; Li G; Feng J; Deng L; Xu H; Yin L; Ma J; Chen D; Chen J
    Front Psychiatry; 2022; 13():941728. PubMed ID: 35958647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder.
    Wang T; Yang J; Zhu Y; Niu N; Ding B; Wang P; Zhao H; Li N; Chao Y; Gao S; Dong X; Wang Z
    J Affect Disord; 2024 Jul; 356():1-12. PubMed ID: 38548210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
    Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
    World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theory of mind impairment and its clinical correlates in patients with schizophrenia, major depressive disorder and bipolar disorder.
    Wang YY; Wang Y; Zou YM; Ni K; Tian X; Sun HW; Lui SSY; Cheung EFC; Suckling J; Chan RCK
    Schizophr Res; 2018 Jul; 197():349-356. PubMed ID: 29122405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of optical coherence tomography studies in schizophrenia, bipolar disorder and major depressive disorder.
    Prasannakumar A; Kumar V; Mailankody P; Appaji A; Battu R; Berendschot TTJM; Rao NP
    World J Biol Psychiatry; 2023 Oct; 24(8):707-720. PubMed ID: 37070475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Inflammatory Marker Abnormalities in Major Psychiatric Diseases: a Systematic Review of Postmortem Brain Studies.
    Ai YW; Du Y; Chen L; Liu SH; Liu QS; Cheng Y
    Mol Neurobiol; 2023 Apr; 60(4):2116-2134. PubMed ID: 36600081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher serum VGF protein levels discriminate bipolar depression from major depressive disorder.
    Chen S; Jiang H; Hou Z; Yue Y; Zhang Y; Zhao F; Xu Z; Li Y; Mou X; Li L; Wang T; Zhao J; Han C; Sui Y; Wang M; Yang Z; Lu Y; Zhu Y; Li J; Shen X; Sun F; Chen Q; Yuan Y
    J Neurosci Res; 2019 May; 97(5):597-606. PubMed ID: 30575991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary composite of blood-based biomarkers to distinguish major depressive disorder and bipolar disorder in adolescents and adults.
    Huang J; Hou X; Li M; Xue Y; An J; Wen S; Wang Z; Cheng M; Yue J
    BMC Psychiatry; 2023 Oct; 23(1):755. PubMed ID: 37845658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDgene: a genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder.
    Chang SH; Gao L; Li Z; Zhang WN; Du Y; Wang J
    Biol Psychiatry; 2013 Nov; 74(10):727-33. PubMed ID: 23764453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.